The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2019

Filed:

Nov. 29, 2016
Applicant:

Biomerieux, Marcy l'Etoile, FR;

Inventors:

Yasemin Ataman-Onal, Reyrieux, FR;

Soizic Daniel, Trevoux, FR;

Nadège Goutagny, Lyons, FR;

Françoise Luciani, Saint-Jean des Vignes, FR;

Assignee:

BIOMERIEUX SA, Marcy l'Etoile, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); C12N 15/86 (2006.01); C12N 15/861 (2006.01); C12N 7/00 (2006.01); A61K 9/51 (2006.01); G01N 33/576 (2006.01); C07K 14/005 (2006.01); C07K 14/10 (2006.01); C07K 16/10 (2006.01);
U.S. Cl.
CPC ...
G01N 33/576 (2013.01); C07K 14/005 (2013.01); C07K 14/10 (2013.01); C07K 16/10 (2013.01); C12N 2770/28122 (2013.01);
Abstract

Polypeptides of the p-ORF2 protein of the hepatitis E virus, including at least the amino acid sequence 394-660, numbered in relation to a p-ORF2 protein of 660 amino acids, in which the three cysteines at positions 627, 630 and 638 have been mutated or, for a p-ORF2 protein of different length, at least the amino acid sequence corresponding to amino acids 394-660 of the p-ORF2 protein of 660 amino acids, in which the three cysteines located at the three positions corresponding to positions 627, 630 and 638 of the p-ORF2 protein of 660 amino acids have been mutated. Also, methods for determining the presence of the humoral response or the titer of antibodies directed against the p-ORF2 protein using these polypeptides, and also the use thereof in the context of infection with the hepatitis E virus.


Find Patent Forward Citations

Loading…